Thu 20 Aug 2026
All official websites of government entities in the Kingdom of Saudi Arabia end with.gov.sa.
Ensure the website is using the HTTPS protocol.
Registered with the Digital Government Authority under number:
| Study Title | Study Sponsor | Status | Study Drug | Trial Phase | Study Protocol Number | Site |
|---|---|---|---|---|---|---|
| An observational, prospective cohort study to evaluate the safety and effectiveness of Remsima® in the treatment of inflammatory bowel disease among Saudi Arabia patients diagnosed with Crohn’s disease, ulcerative colitis, or fistulizing CD | Hikma Pharmaceuticals | Ongoing | Remsima | 4 | RMS-KSA-20 | King Abdulaziz University Hospital (Jeddah) |
| Ibrutinib Before and After Stem Cell Transplant in Treating Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma | SWOG (Southwest Oncology Group) | Ongoing | Ibrutinib | 3 | A051301 | King Faisal Specialist Hospital and Research Center (Riyadh) |
| Randomized, two-way, two-period, single injectable dose, open-label, crossover, bioequivalence study to compare Enoxa pre-filled syringes (80 mg enoxaparin sodium) versus Clexane® pre-filled syringes (80 mg enoxaparin sodium), in healthy subjects under fasting condition. | MEDIS Laboratories | Ongoing | Enoxa / Enoxaparin | BE | 21-2017 v.02 | Saudi Ajal |
| OPEN LABEL, RANDOMIZED, SINGLE SITE CLINICAL TRIAL TO COMPARE THE SAFETY & EFFICACY OF HERBAL MELANIN EXTRACTED FROM NIGELLA SATIVA SEEDS VS STANDARD OF CARE TREATMENT IN TREATING GASTRITIS PATIENTS | KAIMRC | Rejected | Melanole NIGELLA SATIVA | 2 | RC15/152/R | N/A |
| ATOS study_A 12–month prospective observational study assessing the real-world clinical effectiveness, safety and health-economic benefits of Toujeo® initiation after oral antidiabetic drug failure in insulin-naïve patients with type 2 diabetes mellitus | SANOFI | Ongoing | TOUJEO | 4 | OBS14708 | King Abdulaziz University Hospital (Jeddah), Dr. Ghassan N. Pharaon General Hospital (Jeddah), Dallah Hospital (Riyadh), Alzafer Hospital (Najran), Dr. Bakhsh Hospital (Jeddah), Saudi German Hospital (Jeddah), Arrawdha General Hospital (Dammam), Almana Hospital (Jubail), Almouwasat Hospital (Dammam), Specialized Medical Center (Riyadh) |
| "A 12-week, multicenter, randomized, double-blind, placebo-controlledstudy to assess the efficacy and safety of QAW039 when added tostandard-of-care asthma therapy in patients with uncontrolled asthma" | Novartis | Ongoing | QAW039/Fevipiprant | 3 | CQAW039A2316 | King Fahad Medical City (Riyadh), King Abdulaziz Medical City NG (Jeddah) |
| "A 2-treatment period, randomized, placebo-controlled,multicenter parallel-group study to assess the safety ofQAW039 when added to existing asthma therapy in GINAsteps 3, 4 and 5 patients with uncontrolled asthma" | Novartis | Ongoing | QAW039/Fevipiprant | 3 | CQAW039A2315 | King Fahad Medical City (Riyadh), King Abdulaziz Medical City NG (Jeddah) |
| Randomized, four-way, four-period, single oral dose, open-label, crossover, bioequivalence study to compare Tacrolimus Immediate-release capsules (5 mg tacrolimus) versus Prograf® Immediate-release capsules (5 mg tacrolimus), in healthy subjects under fasting conditions. | MEDIS Laboratories | Ongoing | Tacrolimus/ Prograf | BE | 19-2017 | Saudi Ajal |
| "A PHASE III, MULTICENTER,RANDOMISED, DOUBLEBLIND,PLACEBOCONTROLLEDSTUDY OF ATEZOLIZUMAB (ANTI−PDL1 ANTIBODY) IN COMBINATION WITH PACLITAXEL COMPARED WITH PLACEBO WITH PACLITAXEL FOR PATIENTS WITH PREVIOUSLY UNTREATED INOPERABLE LOCALLY ADVANCED OR METASTATIC TRIPLE NEGATIVE BREAST CANCER" | Roche | Ongoing | ATEZOLIZUMAB / PACLITAXEL | 3 | MO39196 | International Medical Center (Jeddah), King Fahad Specialist Hospital (Dammam), King Fahad Medical City (Riyadh) |
| A Randomized, Open-Label, Phase 3 Study of Abemaciclib combined with Standard Adjuvant Endocrine Therapy versus Standard Endocrine Therapy Alone in Patients with High Risk Node Positive Early Stage Hormone Receptor Positive, Human Epidermal Receptor 2 Negative Breast Cancer | Eli Lilly | Ongoing | abemaciclib | 3 | I3Y-MC-JPCF | King Fahad Medical City (Riyadh), King Faisal Specialist Hospital and Research Center (Riyadh), King Fahad Specialist Hospital (Dammam) |
Last update date: 08/05/2025 at 03:17 PM Saudi Arabia time
No feedback has been submitted for this page yet.
Comments and Suggestions
For any inquiries or comments about the government services, please fill in the required information.